SEATTLE--(BUSINESS WIRE)--MitoPharm Corporation, Inc. (Pink Sheets:MTPM), announced today that patent applications on the applications and the product formulas have been filed with the United States Patent and Trademark Office and under the International Patent Convention Treaty. MitoPharm believes that its products have the potential to play a significant role in addressing the aging concerns of the baby boomers, the heart-health and heart-diseases markets, and the segment of the population that is physically active.
